WINDTREE THERAPEUTICS INC Business Finance Contracts & Agreements
150 Contracts & Agreements
- Credit Agreements (2 contracts)
- Exchange Agreements (2)
- Facility Agreements (3)
- Financing Agreements (1)
- Guaranty Agreements (1)
- Loan Agreements (20)
- Note Agreements (10)
- Purchase Agreements (13)
- Registration Rights Agreements (14)
- Security Agreements (4)
- Stock Agreements (22)
- Subscription Agreements (1)
- Term Sheets (1)
- Underwriting Agreements (9)
- Warrant Agreements (47)
- Form of Registration Rights Agreement (Filed With SEC on July 29, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on July 29, 2024)
- Form of Warrant (Filed With SEC on July 29, 2024)
- Form of Registration Rights Agreement (Filed With SEC on July 22, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on July 22, 2024)
- Form of Warrant (Filed With SEC on July 22, 2024)
- Form of Senior Secured Note due 2025 (Filed With SEC on July 10, 2024)
- Form of Senior Unsecured Promissory Note due 2025 (Filed With SEC on July 10, 2024)
- Registration Rights Agreement, dated as of June 26, 2024, by and between Windtree Therapeutics, Inc. and the Purchaser (Filed With SEC on July 1, 2024)
- Common Stock Purchase Agreement, dated as of June 26, 2024, by and between Windtree Therapeutics, Inc. and the Purchaser (Filed With SEC on July 1, 2024)
- Form of Senior Secured Notes due 2025 (Filed With SEC on July 1, 2024)
- Convertible Promissory Note by and between the Company and the Purchaser, dated as of June 26, 2024 (Filed With SEC on July 1, 2024)
- Form of Registration Rights Agreement, by and between Windtree Therapeutics, Inc. and the Buyers named therein, dated April 2, 2024 (Filed With SEC on April 8, 2024)
- Form of Securities Purchase Agreement by and between Windtree Therapeutics, Inc. and the Buyers named therein, dated April 2, 2024 (Filed With SEC on April 8, 2024)
- Form of 10% Convertible Note (Filed With SEC on April 8, 2024)
- Form of Asset Purchase Agreement by and between Windtree Therapeutics, Inc. and Varian Biopharmaceuticals, Inc., dated April 2, 2024 (Filed With SEC on April 8, 2024)
- Registration Rights Agreement, by and between the Company and affiliates of Deerfield Management Company, L.P., effective upon January 24, 2024 (Filed With SEC on January 25, 2024)
- Exchange and Termination Agreement, by and between the Company and affiliates of Deerfield Management Company, L.P., effective upon January 24, 2024 (Filed With SEC on January 25, 2024)
- Warrant Agency Agreement (including form of global Common Warrant), dated April 24, 2023, by and between the Company and Continental Stock Transfer & Trust Company (Filed With SEC on April 24, 2023)
- Underwriting Agreement, dated April 20, 2023, by and between the Company and Ladenburg Thalmann & Co. Inc (Filed With SEC on April 24, 2023)
- Form of Warrant Agency Agreement (Filed With SEC on April 7, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on April 7, 2023)
- Form of Common Warrant (Filed With SEC on April 7, 2023)
- Form of Underwriting Agreement (Filed With SEC on April 7, 2023)
- Form of New Warrant (Filed With SEC on February 22, 2023)
- Form of New Warrant (Filed With SEC on January 26, 2023)
- Form of Warrant Agency Agreement (Filed With SEC on March 24, 2021)
- Form of Warrant (Filed With SEC on March 24, 2021)
- Underwriting Agreement, dated March 23, 2021, by and among the Company and Oppenheimer & Co. Inc., as representative for the several underwriters named therein (Filed With SEC on March 24, 2021)
- Project Financing Agreement, dated August 12, 2020, by and between Windtree and Lees Pharmaceutical (HK) Ltd (Filed With SEC on November 16, 2020)
- Form of Warrant Agency Agreement between Windtree Therapeutics, Inc. and Continental Stock Transfer and Trust Company (Filed With SEC on May 22, 2020)
- Form of Warrant to be issued to purchasers of units and the underwriters pursuant to the Registration Statement on Form S-1, filed on January 27, 2020, as amended (Filed With SEC on May 22, 2020)
- Form of Warrant to be issued to purchasers of units and the underwriters pursuant to this Registration Statement on Form S-1 (Filed With SEC on May 19, 2020)
- Form of Underwriting Agreement (Filed With SEC on May 19, 2020)
- Form of Warrant to be issued to purchasers of units and the underwriters pursuant to this Registration Statement on Form S-1 (Filed With SEC on May 14, 2020)
- Loan Agreement dated March 17, 2020, between CVie Therapeutics, Lees Pharmaceutical Holdings Limited, and O-Bank Co., Ltd (Filed With SEC on May 6, 2020)
- Binding Term Sheet dated March 18, 2020, between Windtree and Lees Pharmaceutical (HK) LTD (Filed With SEC on May 6, 2020)
- Form of Series I Warrant Amendment dated May 6, 2020 to the Series I Warrant dated December 6, 2019 (Filed With SEC on May 6, 2020)
- Form of Warrant Agreement between Windtree Therapeutics, Inc. and Continental Stock Transfer and Trust Company (Filed With SEC on May 6, 2020)
- Form of Warrant to be issued to purchasers of units and the underwriters pursuant to this Registration Statement on Form S-1 (Filed With SEC on May 6, 2020)
